Abell F, Krams M, Ashburner J, Passingham R, Friston K, Frackowiak R, Happe F, Frith C, Frith U (1999). The neuroanatomy of autism: A voxel based whole brain analysis of structural scans. Neuroreport 10:1647-1651. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J (1993). Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4:147-153. Alaghband-Rad J, McKenna K, Gordon CT, Albus KE, Hamburger SD, Rumsey JM, Frazier JA, Lenane MC, Rapoport JL (1995). Childhood-onset schizophrenia: The severity of premorbid course. J Am Acad Child Adolesc Psychiatry 34:1273-1283. Alsobrook JP, Grigorenko E, Pauls DL (2002). Genetic influences on child psychiatric conditions. In Lewis M (ed). Child and Adolescent Psychiatry. A Comprehensive Textbook. Lippincott Williams & Wilkins: Philadelphia, pp. 415-431. Altemus M, Jacobson KR, Debellis M, Kling M, Pigott T, Murphy DL, Gold PW (1994). Normal CSF oxytocin and NPY levels in OCD. Biol Psychiatry 45:931-933. Anderson GM, Cook EH (2000). Pharmacogenetics. Promise and potential in child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am 9:23-42, viii. Anderson GM, Pollak ES, Chattete D, Leckman JF, Riddle MA, Cohen DJ (1992). Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 58:123-133.

Anderson GM, Leckman JF, Cohen DJ (1999). Neurochemical and neuropeptide systems. In Leckman JF, Cohen DJ (eds). Tourette's Syndrome: Tics, Obsessions, Compulsions. Developmental Psychopathology and Clinical Care. Wiley: New York, pp. 261-280. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 7:831-836. Armstrong DD (2002). Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:72-76.

August GJ, Stewart MA, Tsai L (1981). The incidence of cognitive disabilities in the siblings of autistic children. Br J Psychiatry 138:416-422.

Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T, Sinsheimer JS, Pelto-nen L, Jarvela I (2002). A genomewide screen for autism-spectrum disorders: Evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 71:777-790.

Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB (1996). Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 11:112-115.

Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, Barta PE, Pearlson GD (1999). MRI volumes of amygdala and hippocampus in nonmentally retarded autistic adolescents and adults. Neurology 53:2145-2150.

Bachevalier J (1994). Medial temporal lobe structures and autism: A review of clinical and experimental findings. Neuropsychologia 32:627-648.

Badner JA, Gershon ES (2002). Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Mol Psychiatry 7:56-66.

Baer L (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 55:18-23.

Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M (1995). Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 25:63-77.

Bailey A, Phillips W, Rutter M (1996). Autism: Towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry 37:89-126.

Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P (1998). A clinicopathological study of autism. Brain 121:889-905.

Barkley RA (1997). ADHD and the Nature of Self-Control. Guilfor Press, New York.

Barkley RA, Fischer M, Smallish L, Fletcher K (2003). Does the treatment of Attention-Deficit/Hyperactivity Disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111:97-109.

Baron-Cohen S (1991). The development of a theory of mind in autism: Deviance and delay? Psychiatr Clin North Am 14:33 -51.

Baron-Cohen S, Ring H, Moriarty J, Schmidt B, Costa D, Ell P (1994). Recognition of mental state terms: Clinical findings in children with autism and a functional neuroimaging study of normal adults. Brit J Psychiatry 165:640-649.

Barthelemy C, Bruneau N, Cottet-Eymard JM, Domenech-Jouve J, Garreau B, Lelord G, Muh JP, Peyrin L (1988). Urinary free and conjugated catecholamines and metabolites in autistic children. J Autism Dev Disord 18:583-591.

Bauman ML, Kemper TL (1994). Neuroanatomic observations of the brain in autism. In Bau-man ML, Kemper TL (eds). The Neurobiology of Autism. Johns Hopkins University Press: Baltimore, pp. 119-145.

Bauman ML, Kemper TL (1996). Observations on the Purkinje cells in the cerebellar vermis in autism. J Neuropath Exp Neurol 55:613.

Baxter L, Schwartz J, Mazziotta J, Phelps ME, Pahl JJ, Buze BE, Fairbanks L (1988). Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 145:1560-1563.

Baxter L, Jr, Schwartz JM, Bergman KS, SzubaMP, GuzeBH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, Phelps ME (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49:681-689.

Belichenko PV, Oldfors A, Hagberg B, Dahlstrom A (1994). Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 5:1509-1513.

Bellugi U, Lichtenberger L, Mills D, Galaburda A, Korenberg JR (1999). Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome. TINS 22:197-207.

Benazon NR, Moore GJ, Rosenberg DR. (2002). Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: An open trial. Behav Res Ther 40:529-539.

Berg CZ, Rapoport JL, Whitaker A, Davies M, Leonard H, Swedo SE, Braiman S, Lenane M (1989). Childhood obsessive compulsive disorder: A two-year prospective follow-up of a community sample. J Am Acad Child Adolesc Psychiatry 28:528-533.

Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR (1997). Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: A proton magnetic resonance spectroscopic imaging study. Cereb Cortex 7: 740-748.

Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR (1998). Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 155:1376-1383.

Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R (1992). Further evidence for family genetic risk factors in ADHD: Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738.

Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R (1995). High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. Am J Psychiatry 152: 431-435.

Biederman J, Wilens T, Mick E, Spencer T, Faraone SV (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:e20.

Biederman J, Mick E, Faraone SV (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 157:816-818.

Birken DL, Oldendorf WH (1989). N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehavior Rev 13: 23-31.

Bolton PF, Griffiths PD (1997). Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349:392-395.

Bolton PF, Murphy M, Macdonald H, Whitlock B, Pickles A, Rutter M (1997). Obstetric complications in autism: Consequences or causes of the condition? J Am Acad Child Adolesc Psychiatry 36:272-281.

Boucher J, Lewis V (1992). Unfamiliar face recognition in relatively able autistic children. J Child Psychol Psychiatry 33:843-859.

Bouvard MP, Leboyer M, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, Tibuteau F, Bondoux D, Dugas M, Lensing P, Panksepp J. (1995). Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study. Psychiatry Res 58:191-201.

Boyar FZ, Whitney MM, Lossie AC, Gray BA, Keller KL, Stalker HJ, Zori RT, Geffken G, Mutch J, Edge PJ, Voeller KS, Williams CA, Driscoll DJ (2001). A family with a grand-maternally derived interstitial duplication of proximal 15q. Clin Genet 60:421-430.

Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, Carson RE, Herscovitch P, Chase TN (1993). The functional neuroanatomy of Tourette's syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 9:277-291.

Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, O'Sullivan RL, Savage CR, Jenike MA, Rosen BR (1996). Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 53:595-606.

Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J (1999). Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 45:1542-1552.

Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 32:1283-1291.

Cantwell D (1975). Genetic studies on hyperactive children: Psychiatric illness in biologic and adoptive parents. In Fieve R, Rosenthal D, Brill H (eds). Genetic Research in Psychiatry. Johns Hopkins University Press: Baltimore,

Cassidy SB, Dykens E, Williams CA (2000). Prader-Willi and Angelman syndromes: Sister imprinted disorders. Am J Med Genet 97:136-146.

Castellanos FX, Tannock R, (2002). Neuroscience of attention-deficit/hyperactivity disorder. The search for endophenotypes. Nature Revs Neurosci 3:617-628.

Castellanos FX, Giedd JN, Hamburger SD, Marsh WL, Rapoport JL (1996a). Brain morphometry in Tourette's syndrome: The influence of comorbid attention-deficit/hyperactivity disorder. Neurology 47:1581-1583.

Chabot RJ, Serfontein G (1996). Quantitative electroencephalographic profiles of children with Attention Deficit Disorder. Biol Psychiatry 40:951 -963.

Chabrol H, Guell A, Bes A, Moron P (1986). Cerebral blood flow in schizophrenic adolescents [letter]. Am J Psychiatry 143:130.

Chappell P, Riddle M, Anderson G, Scahill L, Hardin M, Walker D, Cohen D, Leckman J (1994). Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biol Psychiatry 36:35-43.

Charman T, Cass H, Owen L, Wigram T, Slonims V, Weeks L, Wisbeach A, Reilly S (2002). Regression in individuals with Rett syndrome. Brain Dev 24:281 -283.

Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT (1997). Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401-5404.

Comings DE, Comings BG (1987). A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genetics 41:701-741.

Cook EH (1990). Autism: Review of neurochemical investigation. Synapse 6:292-308.

Cook EH, Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.

Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV (1994). Neuropathology of Rett syndrome: Case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol 9:424-431.

Costello EJ, Angold A, Burns BJ, Stangl DK, Tweed DL, Erkanli A, Worthman CM (1996). The Great Smoky Mountains study of youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry 53:1129-1136.

Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL (1988). Hypoplasia of cerebellar vermal lobules VI and VII in autism. New Eng L Med 318:1349-1354.

Courchesne E, Townsend J, Saitoh O (1994). The brain in infantile autism: Posterior fossa structures are abnormal. Neurology 44:214-223.

Croonenberghs J, Delmeire L, Verkerk R, Lin AH, Meskal A, Neels H, Van der Planken M, Scharpe S, Deboutte D, Pison G, Maes M (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsy-chopharmacology 22:275-283.

Davies W, Isles AR, Wilkinson LS (2001). Imprinted genes and mental dysfunction. Ann Med 33:428-436.

Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman JJ (1999). Dopamine transporter density is elevated in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133.

Eapen V, Pauls DL, Robertson MM (1993). Evidence for autosomal dominant transmission in Tourette's syndrome. United Kingdom cohort study. Br J Psychiatry 162:593-596.

Epperson CN, McDougle CJ, Price LH (1996). Intranasal oxytocin in Obsessive-Compulsive Disorder. Biol Psychiatry 40:547-549.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM (1997). Reduced medial prefrontal dopaminergic activity in autistic children. Lancet 350:638.

Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM (1999). High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 38:86-94.

Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, Sprich S, Tsuang M (1992). Segregation analysis of attention deficit hyperactivity disorder: Evidence for single gene transmission. Psychiatr Genetics 2:257-275.

Faraone SV, Doyle AE, Mick E, Biederman J (2001). Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057.

Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM (1997). Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.

Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J (1997). Volumetric MRI analysis comparing attention-deficit hyperactivity disorder and normal controls. Neurology 48:589-601.

Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL (2002). A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70:1183-1196.

Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR (2000). Proton spectro-scopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 47:174-182.

Folstein S, Rutter M (1977). Infantile autism: A genetic study of 21 twin pairs. J Child Psychol Psychiatry 18:297-321.

Fombonne E (1999). The epidemiology of autism: A review. Psychol Med 29:769-786.

Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, Lenane MC, McKenna K, Breier A, Rapoport JL (1996). Childhood-onset schizophrenia: Brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 153:564-566.

Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, Posse S, Dager SR (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 60:100-107.

Fuster JM (1997). The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe, 3rd ed. Lippincott-Raven: Philadelphia.

Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S, Coffey B (1998). Is juvenile Obsessive-Compulsive Disorder a developmental subtype of the disorder: A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 37:420-427.

Giedd JN, Jeffries NO, Blumenthal J, Castellanos FX, Vaituzis AC, Fernandez T, Hamburger SD, Liu H, Nelson J, Bedwell J, Tran L, Lenane M, Nicolson R, Rapoport JL (1999). Childhood-onset schizophrenia: Progressive brain changes during adolescence. Biol Psychiatry 46:892-898.

Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR (2000). Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57:449-456.

Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997). Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313.

Gillberg IC (1991). Autistic syndrome with onset at age 31 years: Herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol 33:912-929.

Glaze DG (2002). Neurophysiology of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:66-71.

Goel V, Grafman J, Sadato N, Hallett M (1995). Modeling other minds. Neuroreport 6: 1741-1746.

Grados MA, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ, Walkup JT, Song D, Nestadt G (2001). The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: The Hopkins OCD family study. Biol Psychiatry 50:559-565.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26S-49S.

Group MC (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086.

Group MC (1999b). Moderator and mediator challenges to the MTA study: Effects of comorbid anxiety disorder, family poverty, session attendance, and community medication on treatment outcome. Arch Gen Psychiatry 56:1088-1096.

Gunnar MR (2001). Effects of early deprivation: Findings from orphanage-reared infants and children. In Nelson CA, Luciana M (eds). Handbook of Developmental Cognitive Neuroscience. Massachusetts Institute of Technology: Cambridge MA, pp. 617-629.

Hagberg B (2002). Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:61-65.

Hagerman RJ (1999). Fragile X Syndrome. In Neurodevelopmental Disorders: Diagnosis and Treatment. Oxford University Press: New York, pp. 61-132.

Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH, Jr (2002). Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 114:541 -552.

Happe F, Briskman J, Frith U (2001). Exploring the cognitive phenotype of autism: Weak "central coherence" in parents and siblings of children with autism: I. Experimental tests. J Child Psychol Psychiatry 42:299-307.

Harlow HF, Dodsworth RO, Harlow MK (1965). Total social isolation in monkeys. Proc Natl AcadSci USA 54:90-97.

Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E (1997). Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry 154:1047-1050.

Hendren RL, De Backer I, Pandina GJ (2000). Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. J Am Acad Child Adolesc Psychiatry 39:815-828.

Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M (1993). Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36-43.

Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff HB, Arnold LE, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Swanson JM, Vitiello B, Wigal T (2000). Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol 28:555-568.

Hjalgrim H, Jacobsen TB, Norgaard K, Lou HC, Brondum-Nielsen K, Jonassen O (1999). Frontal-subcortical hypofunction in the fragile X syndrome. Am J Med Genet 83:140-141.

Hobson RP (1986). The autistic child's appraisal of expressions of emotion: A further study. J Child Psychol Psychiatry 2:671 -680.

Hoehn-Saric R, Pearlson G, Harris G, Machlin S, Camargo E (1991). Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 148:1243-1245.

Hoon AH, Reiss AL (1992). The mesial-temporal lobe and autism: Case report and review. Dev Med Child Neurol 34:252-259.

Horska A, Naidu S, Herskovits EH, Wang PY, Kaufmann WE, Barker PB (2000). Quantitative MR spectroscopic imaging in early Rett syndrome. Neurology 54:715-722.

Hyde TM, Aaronson BA, Randolph C, Weinberger DR (1995). Cerebral morphometric abnormalities in Tourette's syndrome: A quantitative MRI study of monozygotic twins. Neurology 45:1176-1182.

Insel TR, O'Brien DJ, Leckman JF (1999). Oxytocin, vasopressin, and autism: Is there a connection? Biol Psychiatry 45:145-157.

Jacobsen LK, Rapoport JL (1998). Research update: Childhood-onset schizophrenia: Implications of clinical and neurobiological research. J Child Psychol Psychiatry 39:101-113.

Jakala P, Hanninen T, Ryynanen M, et al. (1997). Fragile-X: Neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes. J Clin Invest 100:331 -338.

Jones W, Hesselink J, Courchesne E, Duncan T, Matsuda K, Bellugi U (2002). Cerebellar abnormalities in infants and toddlers with Williams syndrome. Dev Med Child Neurol 44:688-694.

Khong PL, Lam CW, Ooi CG, Ko CH, Wong VC (2002). Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome. Pediatr Neurol 26:205-209.

King JA, Barkley RA, Delville Y, Ferris CF (2000). Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav Brain Res 107:35-43.

Kleiman MD, Neff S, Rosman NP (1992). The brain in infantile autism: Are posterior fossa structures abnormal? Neurology 42:753-760.

Klin A, Sparrow SS, de Bildt A, Cicchetti DV, Cohen DJ, Volkmar FR (1999). A normed study of face recognition in autism and related disorders. J Autism Devel Dis 29:499-508.

Kolmen BK, Feldman HM, Handen BL, Janosky JE (1997). Naltrexone in young autistic children: Replication study and learning measures. J Am Acad Child Adolesc Psychiatry 36: 1570-1578.

Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285:107-110.

Lahat E, Avital E, Barr J, Berkovitch M, Arlazoroff A, Aladjem M (1995). BAEP studies in children with attention deficit disorder. Devel Med Child Neurol 37:119-123.

Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H, Folstein SE (1997). Macro-cephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 36:282-290.

Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991). Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324-328.

Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ (1994). Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 51:782-792.

Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, Walker DE, Scahill LD, Ort SI, Pauls DL, Cohen DJ, Price LH (1995). Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 12:73-86.

Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL (1997). Symptoms of Obsessive-Compulsive Disorder. Am J Psychiatry 154:911-917.

Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim Y-S, Peterson BS (1998). Course of tic severity in Tourette's syndrome: The first two decades. Pediatrics 102:14-19.

LeDoux JE (1996). The Emotional Brain: The Mysterious Underpinnings of Emotional Life. Simon & Schuster: New York.

Lekman A, Witt-Engerstrom I, Gottfries J, Hagberg BA, Percy AK, Svennerholm L (1989). Rett syndrome: Biogenic amines and metabolites in postmortem brain. Pediatr Neurol 5:357-62.

Leonard HL, Goldberger EL, Rapoport JL, Cheslow DL, Swedo SE (1990). Childhood rituals: Normal development or obsessive-compulsive symptoms? J Am Acad Child Adolesc Psychiatry 29:17-23.

Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL (1992). Tics and Tourette's disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 149:1244-1251.

Levy F, Hay DA, McStephen M, Wood C, Waldman I (1997). Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36:737-744.

Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 41: 1431-1438.

Lin H, Yeh C-B, Peterson BS, Scahill L, Grantz H, Findley DB, Katsovich L, Okta J, Lom-broso PJ, King RA, Leckman JF (2002). Assessment of symptom exacerbations in a longitudinal study of children with Tourette syndrome or obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 41:1070-1077.

Lipani JD, Bhattacharjee MB, Corey DM, Lee DA (2000). Reduced nerve growth factor in Rett syndrome postmortem brain tissue. J Neuropathol Exp Neurol 59:889-895.

Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, Lord C, Iversen P, Hoh J, Ott J, Gilliam TC (2001). A genomewide screen for autism susceptibility loci. Am J Hum Genet 69:327-340.

Luxenberg JS, Swedo SE, Flament MF, Friedland RP, Rapoport J, Rapoport SI (1988). Neu-roanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry 145:1089-1093.

Maestrini E, Paul A, Monaco AP, Bailey A (2000). Identifying autism susceptibility genes. Neuron 28:19-24.

March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752-1756.

Martineau J, Barthelemy C, Jouve J, Muh JP, Lelord G (1992). Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Dev Med Child Neurol 34:593-603.

Mazzocco MM, Kates WR, Baumgardner TL, Freund LS, Reiss AL (1997). Autistic behaviors among girls with fragile X syndrome. J Autism Dev Disord 27:415-435.

McArdle P, O'Brien G, Kolvin I (1995). Hyperactivity: Prevalence and relationship with conduct disorder. J Child Psychol Psychiatry 36:279-303.

Menon V, Kwon H, Eliez S, Taylor AK, Reiss AL (2000). Functional brain activation during cognition is related to FMR1 gene expression. Brain Res 877:367-370.

Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, Bissonnette L, Roy MA, Maziade M, Ott J, Caron C (2000). Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008 -1013.

Middleton FA, Strick PL (1994). Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 266:458-461.

Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1994). Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 36:237-241.

Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam K, Pettegrew JW (1993). A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33:762-773.

Moll GH, Hause S, Ruther E, Rothenberger A, Huether G (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adoles Psychopharmacology 11:15-24.

Moriarty J, Campos Costa D, Schmitz B, Trimble MR, Ell PJ, Robertson MM (1995). Brain perfusion abnormalities in Gilles de la Tourette's syndrome. Br J Psychiatry 167:249-254.

Morrison JR, Stewart M (1973). The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 28:888-891.

Mostofsky SH, Mazzocco MM, Aakalu G, Warsofsky IS, Denckla MB, Reiss AL (1998a). Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology 50:121-130.

Mostofsky SH, Reiss AL, Lockhart P, Denckla MB (1998b). Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 13:434-439.

Mountz JM, Lelland CT, Lill DW, Katholi CR, Liu H (1995). Functional deficits in autistic disorder: Characterization by Technetium-99m-HMPAO and SPECT. JNuclMed 36:1156-1162.

Nagamitsu S, Matsuishi T, Kisa T, Komori H, Miyazaki M, Hashimoto T, Yamashita Y, Ohtaki E, Kato H (1997). CSF beta-endorphin levels in patients with infantile autism. J Autism Dev Disord 27:155-163.

Narayan M, Srinath S, Anderson GM, Meundi DB (1993). Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 33:630-635.

Nelson DL (1995). The fragile X syndromes. Sem Cell Biol 6:5-11.

Nicholls RD, Knepper JL (2001). Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2:153-175.

Nicolson R, Lenane M, Hamburger SD, Fernandez T, Bedwell J, Rapoport JL (2000). Lessons from childhood-onset schizophrenia. Brain Res Brain Res Rev 31:147-156.

NIH (2000). National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry 39:182-193.

Nocjar C, Panksepp J (2002). Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug- and natural-reward: Interaction with environmental variables. Behav Brain Res 128:189-203.

O'Donnell WT, Warren ST (2002). A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 25:315-338.

Oostra BA, Halley DJJ (1995). Complex behavior of simple repeats: the fragile X syndrome. Pediatric Res 38:629-637.

Overtoom CCE, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, Camf-ferman G, Koelega HS (1998). Associations between event-related potentials and measures of attention and inhibition in the continuous performance task in children with ADHD and normal controls. J Am Acad Child Adolesc Psychiatry 37:977-985.

Panksepp J (1979). A neurochemical theory of autism. Trends Neurosci 2:174-177.

Panksepp J, Burgdorf J, Gordon N, Turner C (2002). Treatment of ADHD with methylphenidate may sensitize brain substrates of desire. Implications for changes in drug abuse potential from an animal model. Consciousness & Emotion 3:7-19.

Panksepp J, Burgdorf J, Turner C, Gordon N (2003). Modeling ADHD-type arousal with unilateral frontal cortex damage in rats and beneficial effects of play therapy. Brain Cognit. 52:97-105.

Papa M, Sergeant JA, Sadile AG (1997). Differential expression of transcription factors in the accumbens of an animal model of ADHD. Neuroreport 8:1607-1612.

Papa M, Berger DF, Sagvolden T, Sergeant JA, Sadile AG (1998). A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior fore-brain of an animal model of Attention Deficit Hyperactivity Disorder. Behav Brain Res 94:197-211.

Parent A, Hazrati L (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 20:91-127.

Pauls DL (2001). Update on the genetics of Tourette syndrome. Adv Neurol 85:281-293.

Pauls DL, Alsobrook JN, Goodman W, Rasmussen S, Leckman JF (1995). A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84.

Pauls DL, Raymond CL, Stevenson JM, Leckman JF (1991). A family study of Gilles de la Tourette syndrome. Am J Hum Genetics 48:154-163.

Pauls DL, Leckman JF, Cohen DJ (1993). Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 32:1044-1050.

Pauls DL, Leckman JF (1986). The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. NEJM 315:993-997.

Peterson BS, Cohen DJ (1998). The treatment of Tourette's syndrome: A multimodal developmental intervention. J Clin Psychiatry 59(Suppl 1). 62-72.

Peterson B, Klein J (1997). Neuroimaging of Tourette's syndrome neurobiologic substrate. In Peterson BS (ed). Child Psychiatry Clinics of North America: Neuroimaging, vol. 6 (April). WB. Saunders: Philadelphia, pp. 343-364.

Peterson BS, Leckman JF (1998). The temporal characteristics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 44:1337-1348.

Peterson BS, Thomas P (2000). Functional brain imaging in Tourette's syndrome: What are we really imaging? In Ernst M, Rumsey J (eds). Functional Neuroimaging in Child Psychiatry. Cambridge University Press: Cambridge, pp. 242-265.

Peterson BS, Riddle MA, Cohen DJ, Katz L, Smith JC, Leckman JF (1993a). Human basal ganglia volume asymmetries on magnetic resonance images. Mag Reson Imaging 11:493-498.

Peterson BS, Leckman JF, Cohen DJ (1995). Tourette's syndrome: A genetically predisposed and an environmentally specified developmental psychopathology. In Cicchetti D, Cohen DJ (eds). Developmental Psychopathology, Vol. 2: Risk, Disorder, and Adaptation. Wiley: New York, pp. 213-242.

Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, Leckman JF, Gore JC (1998). A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 55:326-333.

Peterson BS, Pine DS, Cohen P, Brook J (2001a). A prospective, longitudinal study of tic, obsessive-compulsive, and attention deficit-hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 40:685-695.

Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, Cohen DJ, Gore JC, Albert J, Webster R (2001b). Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 58:427-440.

Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang Z, Bronen R, King R, Leckman JF, Staib L (2003). Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415-424.

Piven J, Nehme E, Simon J, Barta P, Pearlson G, Folstein SE (1992). Magnetic resonance imaging in autism: Measurement of the cerebellum, pons, and fourth ventricle. Biol Psychiatry 31:491-504.

Piven J, Arndt S, Bailey J, Andreasen N (1996). Regional brain enlargement in autism: A magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 35:530-536.

Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF (1985). A twin study of Tourette syndrome. Arch Gen Psychiatry 42:815-820.

Rae C, Karmiloff-Smith A, Lee MA, Dixon RM, Grant J, Blamire AM, Thompson CH, Styles P, Radda GK (1998). Brain biochemistry in Williams syndrome: Evidence for a role of the cerebellum in cognition? Neurology 51:33-40.

Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bed-well J, Lenane M, Zijdenbos A, Paus T, Evans A (1999). Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 56:649-654.

Rasmussen SA, Tsuang MT (1986). Clinical characteristics and family history in DSM-III Obsessive-Compulsive Disorder. Am J Psychiatry 143:317-322.

Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ (1994). Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51:62-70.

Rauch SL, Dougherty DD, Shin LM, Alpert NM, Manzo P, Leahy L, Fischman AJ, Jenike MA, Baer L (1998). Neural correlates of factor-analyzed OCD symptom dimensions: A PET study. CNS Spectrums 3:37-43.

Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN (1991a). Neuroanatomy of fragile X syndrome: The posterior fossa. Ann Neurology 29:26-32.

Reiss AL, Freund L, Tseng JE, Joshi PK (1991b). Neuroanatomy in fragile X females: The posterior fossa. Am J Hum Genetics 49:279-288.

Reiss AL, Lee J, Freund L (1994). Neuroanatomy of fragile X syndrome: the temporal lobe. [Review] Neurology 44:1317-1324.

Reiss AL, Freund LS, Baumgardner TL, Abrams MT, Denckla MB (1995). Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11:331-334.

Reiss AL, Eliez S, Schmitt JE, Patwardhan A, Haberecht M (2000). Brain imaging in neu-rogenetic conditions: Realizing the potential of behavioral neurogenetics research. Mental Retardation & Developmental Disabilities Research Reviews 6:186-197.

Ritvo ER, Mason-Brothers A, Freeman BJ, Pingree C, Jenson WR, McMahon WM, Petersen PB, Jorde LB, Mo A, Ritvo A (1990). The UCLA-University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry 147:1614-1621.

Robinson D, Wu H, Munne RA, Ashtari M, Alvir JMJ, Lerner G, Koreen A, Cole K, Bogerts B (1995). Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 52:393-398.

Rodier PM, Ingram JL, Tisdale B, Nelson SF, Romano J (1996). Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370:247-261.

Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH (2001). Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105:471-478.

Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH (2002). Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114:154-158.

Rosenberg DR, Keshavan MS (1998). Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 43:623-640.

Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ (2000a). Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy. Biol Psychiatry 48:294-300.

Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000b). Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39:1096-1103.

Roy P, Rutter M, Pickles A (2000). Institutional care: Risk from family background or pattern of rearing? J Child Psychol Psychiatry 41:139-149.

Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I (1995). Regional [133]Xenon cerebral blood flow and cerebral [99m]Tc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 38:429-437.

Russell VA (2002). Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Behav Brain Res 130:191-196.

Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR (1998). Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 393:169-171.

Schmitt JE, Eliez S, Warsofsky IS, Bellugi U, Reiss AL (2001a). Corpus callosum morphology of Williams syndrome: Relation to genetics and behavior. Dev Med Child Neurol 43: 155-159.

Schmitt JE, Eliez S, Warsofsky IS, Bellugi U, Reiss AL (2001b). Enlarged cerebellar vermis in Williams syndrome. J Psychiatr Res 35:225-229.

Schmitt JE, Watts K, Eliez S, Bellugi U, Galaburda AM, Reiss AL (2002). Increased gyrifi-cation in Williams syndrome: Evidence using 3D MRI methods. Dev Med Child Neurol 44:292-295.

Schultz RT, Gauthier I, Klin A, Fulbright R, Anderson A, Volkmar F, Skudlarski P, Lacadie C, Cohen DJ, Gore JC (2000). Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 57:331-340.

Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps ME (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53:109-113.

Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Pay-lor R, Zoghbi H (2002a). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243-254.

Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002b). Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115-124.

Shapiro AK, Shapiro ES, Young JG, Feinberg TE (1988). Signs, symptoms, and clinical course. In Shapiro AK, Shapiro ES, Young JG, Feinberg TE (eds). Gilles de la Tourette Syndrome. Raven Press: New York, pp. 127-193.

Sherman DK, McGue MK, Iacono WG (1997). Twin concordance for attention deficit hyper-activity disorder: A comparison of teachers' and mothers' reports. Am J Psychiatry 154: 532-535.

Sigman M, Mundy P (1989). Social attachments in autistic children. J Am Acad Child Adolesc Psychiatry 28:74-81.

Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, Harris EL, Reader MJ, Chase GA, Bryan RN, Denckla MB (1993). Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 43:950-956.

Sowell ER, Levitt J, Thompson PM, Holmes CJ, Blanton RE, Kornsand DS, Caplan R, McCracken J, Asarnow R, Toga AW (2000). Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am J Psychiatry 157:1475-1484.

Stamenkovic M, Schindler SD, Asenbaum S, Neumeister A, Willeit M, Willinger U, de Zwaan M, Riederer F, Aschauer HN, Kasper S (2001). No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECT-study. Eur Neuropsychopharmacol. 11:69-74.

Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, Bohman M (1989). A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30:405-416.

Stromland K, Nordin V, Miller M, Akerstrom B, Gillberg C (1994). Autism in thalidomide embryopathy: A population study. Dev Med Child Neurol 36:351-356.

Suomi SJ (1973). Surrogate rehabilitation of monkeys reared in total social isolation. J Child Psychol Psychiatry 14:71 -77.

Swedo SE, Leonard HL, Kruesi MJ, Rettew DC, Listwak SJ, Berrettini W, Stipetic M, Hamburger S, Gold PW, Potter WZ, Rapoport JL (1992a). Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 49:29-36.

Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL (1992b). Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49: 690-694.

Szatmari P, Offord DR, Boyle MN (1989). Ontario Child Health Study: Prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry 30:205-218.

Taylor E, Snadberg S, Thorley G, Giles S (1991). The Epidemiology of Childhood Hyperactivity. Institute of Psychiatry, Maudsley Monographs, Vol 33, Oxford University Press: Oxford, UK.

Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J (2002). Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study. BMJ 324:393-396.

Tordjman S, Anderson GM, McBride PA, Hertzig ME, Snow ME, Hall LM, Thompson SM, Ferrari P, Cohen DJ (1997). Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 38:705-715.

Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, Fujita T, Saito H, Minami M, Yoshioka M (2002). Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol 13:1-13.

Urban Z, Helms C, Fekete G, Csiszar K, Bonnet D, Munnich A, Donis-Keller H, Boyd CD (1996). 7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet 59:958-962.

Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Proc Natl Acad Sci USA 95: 14494-14499.

Valleni-Basile LA, Garrison CZ, Waller JL, Addy CL, McKeown RE, Jackson KL, Cuffe SP (1996). Incidence of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 35:898-906.

Van den Veyver IB, Zoghbi HY (2002). Genetic basis of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:82-86.

Villemagne PM, Naidu S, Villemagne VL, Yaster M, Wagner HN, Jr., Harris JC, Moser HW, Johnston MV, Dannals RF, Wong DF (2002). Brain glucose metabolism in Rett Syndrome. Pediatr Neurol 27:117-122.

Volkmar FR, Tsatsanis KD (2002). Childhood schizophrenia. In Lewis M (ed). Child and Adolescent Psychiatry. A Comprehensive Textbook. Lippincott Williams & Wilkins: Philadelphia, pp. 745-754.

Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-400.

Werry JS (1996). Childhood schizophrenia. In Volkmar F (ed). Psychoses and Pervasive Developmental Disorders in Childhood and Adolescence. American Psychiatric Press: Washington, DC, pp. 1-48.

Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003). Does stimulant therapy of Attention-Deficit/Hyperactivity Disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179-185.

Willemsen-Swinkels SH, Buitelaar JK, van Engeland H (1996). The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Biol Psychiatry 39:1023-1031.

Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, Kimball AW, Gjedde A, Dan-nals RF, Ravert HT, Wilson PD, Wagner HNJ (1997). D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 38:1243-1247.

Yamashita Y, Matsuishi T, Ishibashi M, Kimura A, Onishi Y, Yonekura Y, Kato H (1998). Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neurol Sci 154:146-150.

Zametkin AJ, Rapoport JL (1987). Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26: 676-686.

Zhang H, Leckman JF, Pauls DL, Tsai CP, Kidd KK, Campos MR (2002). Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 70:896-904.

The ADHD Success Formula

The ADHD Success Formula

This is an audio and guide that will help you battle through ADHD and Accomplish Twice As Much In Half The Time. Learn more by download your very own copy today.

Get My Free Ebook

Post a comment